“…There has also been increasing focus on second-row transition metal complexes of ruthenium, rhodium and rhenium. [5][6][7] Ru(II) and Ru(III) tripodal amine complexes, especially those of imidazole-based ligands, have been studied for their anti-tumor properties [8] and, in cases where the ligand has π-acceptor groups, such compounds have drawn attention because of their luminescence and redox properties. Oddly, however, some classical coordination compounds of ruthenium with simple multidentate amines appear to be underrepresented in the literature; with tris(2-aminoethyl)amine (Tren), only one Ru(II)-Tren complex [9] and two Ru(III)-Tren [10] complexes having been reported previously (the former during our execution of this work).…”